Bio-Rad Laboratories (BIO) Free Cash Flow Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Bio-Rad Laboratories | 8.23 Bn | 6.66 Bn | 309.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.65% |
| Dec 31, 2025 | -13.47% |
| Sep 30, 2025 | -5.07% |
| Jun 30, 2025 | -0.88% |
| Mar 31, 2025 | 18.30% |
| Dec 31, 2024 | -10.07% |
| Sep 30, 2024 | 12.43% |
| Jun 30, 2024 | -16.12% |
| Mar 31, 2024 | 8.96% |
| Dec 31, 2023 | 28.92% |
| Sep 30, 2023 | -2.94% |
| Jun 30, 2023 | -9.60% |
| Mar 31, 2023 | 36.51% |
| Dec 31, 2022 | 0.70% |
| Sep 30, 2022 | -32.16% |
| Jun 30, 2022 | -12.74% |
| Mar 31, 2022 | 16.37% |
| Dec 31, 2021 | 34.85% |
| Sep 30, 2021 | 30.56% |
| Jun 30, 2021 | 8.62% |
| Mar 31, 2021 | 49.65% |
| Dec 31, 2020 | 98.55% |
| Sep 30, 2020 | 166.85% |
| Jun 30, 2020 | 3.26% |
| Mar 31, 2020 | 77.10% |
| Dec 31, 2019 | 28.65% |
| Sep 30, 2019 | -5.05% |
| Jun 30, 2019 | 18.32% |
| Mar 31, 2019 | -14.83% |
| Dec 31, 2018 | -20.87% |
| Sep 30, 2018 | 12.54% |
| Jun 30, 2018 | 88.94% |
| Mar 31, 2018 | 27.01% |
| Dec 31, 2017 | -4.94% |
| Sep 30, 2017 | -25.12% |
| Jun 30, 2017 | 16.87% |
| Mar 31, 2017 | -193.04% |
| Dec 31, 2016 | -24.72% |
| Sep 30, 2016 | 14.28% |
| Jun 30, 2016 | 0.29% |
| Mar 31, 2016 | -60.52% |
| Dec 31, 2015 | -34.93% |
| Sep 30, 2015 | -55.03% |
| Jun 30, 2015 | 42.93% |
| Mar 31, 2015 | -42.81% |
| Dec 31, 2014 | 101.60% |
| Sep 30, 2014 | -4.66% |